Give Hope Blog

Orange as Cancer Fighter | City of Hope

From Oranges, a Powerful Potential Cancer Fighter

June 13, 2019 | Wayne Lewis

Sharad Singhal, Ph.D., research professor in the Department of Medical Oncology and Therapeutics Research, leads investigations focusing on a small molecule that is abundant in the pith of citrus fruit.

Continue Reading

Ammar Chaudhry

Young investigator wins $1 million ORIEN NOVA Grant

June 11, 2019 | Maxine Nunes

The dynamic young founder and director of City of Hope’s Precision Imaging Lab, Ammar Chaudhry, M.D., is one of the first recipients of the new ORIEN NOVA Award. The $1 million grant will fund research for his breakthrough approach to cancer imaging and diagnosis.

Continue Reading

cancer cell

Breakthrough drug shows results in lung, colon cancer

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Continue Reading

cancer cell

New drug shows strong results against stubborn mutation

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Continue Reading

Querfeld-Christiane

5 things to know about skin cancer with Christiane Querfeld, M.D., Ph.D.

May 24, 2019 | Kevin Chesley

Skin cancer is a largely survivable and curable form of cancer. Even its most rare and aggressive form, melanoma, has a high cure rate thanks to leading-edge treatments. But it’s still important to be careful, according to City of Hope's Christiane Querfeld, M.D., Ph.D.

Continue Reading

Measles Virus | City of Hope

Measles outbreak puts cancer patients at risk

May 15, 2019 | Dory Benford

Chemotherapy, immunotherapy and stem cell transplants wipe out patients’ immune systems, leaving them more vulnerable to bacterial and viral infections such as measles.

Continue Reading

colorectal cancer screening

Colorectal tumor biomarker may predict immunotherapy effectiveness

May 2, 2019 | Zen Vuong

The takeaway of foundational research by a City of Hope physician-scientist and his colleagues is that patients with metastatic colorectal cancer and a high tumor mutation score should consider immunotherapy as initial treatment.

Continue Reading

Back To Top